Literature DB >> 404249

Antitumor activity of a Brucella abortus preparation.

G Keleti, D S Feingold, J S Youngner.   

Abstract

Mice injected intraperitoneally with sarcoma-180 cells develop ascites and eventually die. Intraperitoneal injection of a nonviable, aqueous... ether-extracted Brucella abortus preparation (BRU-PEL) as early as 7 days before or as late as 7 days after injection of tumor cells significantly inhibited development of ascites and protected against death. BRU-PEL was not effective if injected after ascites was grossly apparent. BRU-PEL was significantly more active than a Corynebacterium parvum preparation administered in the same way.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404249      PMCID: PMC421450          DOI: 10.1128/iai.15.3.846-849.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  The effect of Brucella abortus infection on transmissible Crocker's sarcoma in mice.

Authors:  Z HIRNLE
Journal:  Acta Med Pol       Date:  1960

2.  Effect of Bacillus Calmette-Guerin infection on transplanted tumours in the mouse.

Authors:  L J OLD; D A CLARKE; B BENACERRAF
Journal:  Nature       Date:  1959-07-25       Impact factor: 49.962

3.  Treatment of cancer with immunomodulators.

Authors:  H F Oettgen; C M Pinsky; L Delmonte
Journal:  Med Clin North Am       Date:  1976-05       Impact factor: 5.456

4.  Hazards and complications of BCG immunotherapy.

Authors:  F C Sparks
Journal:  Med Clin North Am       Date:  1976-05       Impact factor: 5.456

5.  Antiviral activity of an extract of Brucella abortus: induction of interferon and immunopotentiation of host resistance.

Authors:  E R Kern; L A Glasgow; J C Overall
Journal:  Proc Soc Exp Biol Med       Date:  1976-07

6.  Activity of inactivated Burcella on murine tumors: prophylactic effects and combination with specific immunostimulation.

Authors:  Y Le Garrec; D Sabolovic; L Toujas; L Dazord; J Guelfi; C Pilet
Journal:  Biomedicine       Date:  1974-01-20

7.  Antiviral activity of Brucella abortus preparations; separation of active components.

Authors:  D S Feingold; G Keleti; J S Youngner
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

8.  Suppression of tumor growth and regression of established tumor with oil-attached mycobacterial fractions.

Authors:  Y Yamamura; I Azuma; T Taniyama; E Ribi; B Zbar
Journal:  Gan       Date:  1974-04

9.  Effect of Brucella abortus infection (vaccine strain 19BA) on Rauscher leukemia virus and L1210 leukemia in mice.

Authors:  T K Veskova; K L Chimishkyan; G J Sver-Moldavsky
Journal:  J Natl Cancer Inst       Date:  1974-05       Impact factor: 13.506

10.  Antiviral activity of an ether-extracted nonviable preparation of Brucella abortus.

Authors:  J S Youngner; G Keleti; D S Feingold
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

View more
  2 in total

1.  Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophages.

Authors:  L A Glasgow; J L Crane; C J Schleupner; E R Kern; J S Youngner; D S Feingold
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

2.  Influence of the culture conditions of Brucella abortus on its antitumor properties.

Authors:  B Collet; L Dazord; J Portoukalian; F Sauvager; A Ruffault; C David
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.